AzTrials
AzTrials

ArthrodesisNCT04084262

Multi-Plane Hallux Valgus Correction With the Phantom® Nail

An observational study of Arthrodesis and Bunion, run by Paragon 28 at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this research study is to determine the change in frontal plane rotation of the 1st metatarsal from pre to post arthrodesis of the 1st TMT joint with the Phantom® Intramedullary Nail combined with a supinating reduction technique. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Arthrodesis, Bunion, Hallux Valgus
What is being tested?
Intramedullary Nail
Type of treatment
Medical device
How many people
12 participants
Where
1 siteUnited States
Study dates
7 Nov 2019to 9 May 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population will consist of adults age 18 and older with a hallux valgus deformity. The most common age demographic to have surgery for hallux valgus correction is age 50-59. Additionally, the prevalence of hallux valgus in females is greater than males, so a higher percentage of female subjects seeking treatment is likely to be expected.

Who may be able to join

  • The subject is at least 18 years of age at the time of screening.
  • The subject has been diagnosed with hallux valgus.
  • The subject has pain associated with hallux valgus.
  • The subject agrees to comply with the requirements of the study and complete the study measures.
  • The subject is willing and able to provide written informed consent.
  • The subject plans to undergo a Lapidus Arthrodesis procedure with a 3-Hole Phantom® Intramedullary Nail.

Who cannot join

  • The subject is pregnant.
  • The subject has had previous surgery for hallux valgus on operative side.
  • The subject will require a structural graft in the 1st TMT joint.
  • The unshod foot in question is greater than 28 cm in length.
  • The subject is not expected to complete the study according to the investigation plan.
  • The subject has been deemed physiologically or psychologically inadequate by the enrolling physician.
  • The subject is a prisoner, unable to understand what participation in the study entails, mentally incompetent, a known abuser of alcohol and/or drugs, or anticipated to be non-compliant.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Orthopedic Center of Palm Beach County

    Atlantis, Florida, 33462

Other trials in United States

About this study

Official title: Correction of Multi-Plane Hallux Valgus Deformity Using the Phantom® Intramedullary Nail

The goal of this research study is to determine the change in frontal plane rotation of the 1st metatarsal from pre to post arthrodesis of the 1st TMT joint with the Phantom® Intramedullary Nail combined with a supinating reduction technique.

The study hypothesis is that multi-planar correction can be achieved with the Phantom® Intramedullary Nail.

Read the detailed description

Each subject will undergo a Lapidus Arthrodesis combined with a supinating reduction technique.

The subjects will undergo 3 weight-bearing CBCT scans of their foot and ankle, one pre-arthrodesis, one two weeks post-arthrodesis, and one 12 weeks post-arthrodesis. These scans will be used to determine change in frontal plane rotation of the 1st metatarsal from pre to post arthrodesis of the 1st TMT joint, change in angular/positional alignment of the 1st TMT joint using various measurements (1-2 IMA, Meary's Angle, HVA, MAA, Sesamoid Position, and Sesamoid Frontal Plane Rotation), maintenance of correction of the 1st TMT joint, and union status.

The subjects will also complete three surveys, the Pain and Satisfaction Survey, the AOFAS Hallux MTP-IP Scale, and the FAOS Foot and Ankle Survey, at the Pre-Operative Visit, 2 Week Visit (post-op), 6 Week Visit (post-op), and 12 Week Visit (post-op). Furthermore, the subjects will be asked about their willingness to undergo the procedure again at the 12 Week Visit (post-op). All of these scores will be considered in the secondary objectives.

Aside from the study activities listed above, all procedures, visits, and instructions for the subject are to follow the standard of care.

Being tested
Intramedullary Nail
Keywords
bunion, supinating reduction, multi-plane, lapidus, arthrodesis, intramedullary nail, hallux valgus
Medical subject headings
Ankylosis, Bunion, Hallux Valgus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intramedullary NailDevice

    Also called Phantom® Intramedullary Nail

    Subjects undergo a Lapidus Arthrodesis procedure combined with a supinating reduction technique to create a multi-plane correction of hallux valgus

Study groups in NCT04084262
Study groupRoleWhat they receive
All Study ParticipantsPhantom® Intramedullary Nail combined with a supinating reduction technique
Receives: Device: Intramedullary Nail

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Frontal Plane Rotation

    Determine the change in frontal plane rotation of the 1st metatarsal from pre to post arthrodesis of the 1st tarsometatarsal joint with the Phantom® Intramedullary Nail combined with a supinating reduction technique.

    Measured: 12 weeks

Secondary outcomes (14)
  1. 1-2 Inter Metatarsal Angle

    Change in 1-2 Inter Metatarsal Angle before and after arthrodesis of the 1st tarsometatarsal joint using weightbearing CBCT imaging

    Measured: Pre-op, 2 weeks, 12 weeks

  2. Meary's Angle

    Change in Meary's Angle before and after arthrodesis of the 1st tarsometatarsal joint using weightbearing CBCT imaging

    Measured: Pre-op, 2 weeks, 12 weeks

  3. Hallux Valgus Angle

    Change in Hallux Valgus Angle before and after arthrodesis of the 1st tarsometatarsal joint using weightbearing CBCT imaging

    Measured: Pre-op, 2 weeks, 12 weeks

  4. Metatarsus Adductus Angle

    Change in Metatarsus Adductus Angle before and after arthrodesis of the 1st tarsometatarsal joint using weightbearing CBCT imaging

    Measured: Pre-op, 2 weeks, 12 weeks

  5. Sesamoid Position

    Change in sesamoid position before and after arthrodesis of the 1st tarsometatarsal joint using weightbearing CBCT imaging

    Measured: Pre-op, 2 weeks, 12 weeks

  6. Sesamoid Frontal Plane Rotation

    Change in sesamoid frontal plane rotation before and after arthrodesis of the 1st tarsometatarsal joint using weightbearing CBCT imaging

    Measured: Pre-op, 2 weeks, 12 weeks

  7. Maintenance of Correction

    Maintenance of lapidus arthrodesis correction via CBCT analysis

    Measured: Pre-op, 2 weeks, 12 weeks

  8. Union Status

    Union/delayed union status at 12 Week Visit

    Measured: 12 weeks

  9. Clinical Complications

    Any lapidus arthrodesis related clinical complications

    Measured: Pre-Op, 2 weeks, 6 weeks,12 weeks

  10. Patient Current Level of Pain at Surgical Site

    Visual Analog Scale (VAS). Line from 0 (no pain) to 10 (worst pain). Patient reported.

    Measured: Pre-Op, 2 weeks, 6 weeks, 12 weeks

  11. AOFAS

    Change in AOFAS Hallux Metatarsophalangeal-Interphalangeal Scale scores

    AOFAS Hallux Metatarsophalangeal-Interphalangeal Scale foot clinical score. Pain: 0-40 points Function: 0-45 points Alignment: 0-15 points Total Score (sum): 0-100 points (higher score indicates better outcomes)

    Measured: Pre-Op, 2 weeks, 6 weeks, 12 weeks

  12. FAOS

    Change in FAOS Foot and Ankle Survey scores

    Standardized answer options are given (% Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.

    Subscales:

    Pain Other Symptoms Functions in Daily Living (ADL) Function in sport and recreation Foot and ankle-related Quality of Life (QoL)

    Measured: Pre-Op, 2 weeks, 6 weeks, 12 weeks

  13. Patient Satisfaction with Procedure

    Patient reported satisfaction by check boxes (Likert Scale) from Pain and Satisfaction Survey

    Measured: Pre-Op, 2 weeks, 6 weeks, 12 weeks

  14. Willingness to Undergo Procedure Again

    Willingness to undergo procedure again (Yes/No)

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Sep 2019
  2. Study start7 Nov 2019
  3. Primary completion1 Apr 2022
  4. Study completion9 May 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04084262
Sponsor's protocol ID
P30-SP-0002
Status last verified
Sep 2022
First submitted
6 Sep 2019
Last updated
23 Sep 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Arthrodesis and Bunion, run by Paragon 28 at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Frontal Plane Rotation (time frame: 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in